MX2015006478A - Inhibidores de glutaminasa y metodos de empleo. - Google Patents
Inhibidores de glutaminasa y metodos de empleo.Info
- Publication number
- MX2015006478A MX2015006478A MX2015006478A MX2015006478A MX2015006478A MX 2015006478 A MX2015006478 A MX 2015006478A MX 2015006478 A MX2015006478 A MX 2015006478A MX 2015006478 A MX2015006478 A MX 2015006478A MX 2015006478 A MX2015006478 A MX 2015006478A
- Authority
- MX
- Mexico
- Prior art keywords
- glutamase
- inhibitors
- compounds
- inhibit glutaminase
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
Abstract
En la presente se describen compuestos y composiciones que comprenden compuestos que inhiben la glutaminasa. También se describen en la presente métodos de empleo de los compuestos que inhiben la glutaminasa en el tratamiento del cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261729321P | 2012-11-21 | 2012-11-21 | |
PCT/US2013/071212 WO2014081925A1 (en) | 2012-11-21 | 2013-11-21 | Glutamase inhibitors and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015006478A true MX2015006478A (es) | 2015-12-03 |
MX369691B MX369691B (es) | 2019-11-19 |
Family
ID=49780330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015006478A MX369691B (es) | 2012-11-21 | 2013-11-21 | Inhibidores de glutaminasa y métodos de empleo. |
Country Status (15)
Country | Link |
---|---|
US (3) | US9303002B2 (es) |
EP (1) | EP2922832B1 (es) |
JP (1) | JP6333280B2 (es) |
KR (1) | KR20150085078A (es) |
CN (1) | CN105263915B (es) |
AU (2) | AU2013347933C1 (es) |
BR (1) | BR112015011756A2 (es) |
CA (1) | CA2892089A1 (es) |
EA (1) | EA029531B1 (es) |
ES (1) | ES2761951T3 (es) |
HK (1) | HK1213889A1 (es) |
IL (1) | IL238959A (es) |
MX (1) | MX369691B (es) |
SG (1) | SG11201504022RA (es) |
WO (1) | WO2014081925A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2640918C2 (ru) | 2010-11-01 | 2018-01-12 | Псивида Юэс, Инк. | Биоразлагаемые устройства на основе кремния для доставки терапевтических агентов |
US8604016B2 (en) | 2011-11-21 | 2013-12-10 | Calithera Biosciences Inc. | Heterocyclic inhibitors of glutaminase |
MX2015005963A (es) | 2012-11-16 | 2015-09-16 | Calithera Biosciences Inc | Inhibidores heterociclicos de glutaminasa. |
EP2922832B1 (en) | 2012-11-21 | 2019-10-09 | Agios Pharmaceuticals, Inc. | Glutaminase inhibitors and methods of use |
WO2014079011A1 (en) | 2012-11-22 | 2014-05-30 | Agios Pharmaceuticals, Inc. | Heterocyclic compounds for inhibiting glutaminase and their methods of use |
JP6783663B2 (ja) | 2014-01-06 | 2020-11-11 | ライゼン・ファーマシューティカルズ・エスアー | 新規グルタミナーゼ阻害剤 |
EA201691896A1 (ru) | 2014-03-21 | 2017-01-30 | Аджиос Фармасьютикалз, Инк. | Соединения и способы их применения |
PT3137460T (pt) | 2014-04-30 | 2019-12-30 | Pfizer | Derivados de di-heterociclo ligado a cicloalquilo |
GB201409624D0 (en) | 2014-05-30 | 2014-07-16 | Astrazeneca Ab | 1,3,4-thiadiazole compounds and their use in treating cancer |
JP6798890B2 (ja) * | 2014-06-13 | 2020-12-09 | キャリセラ バイオサイエンシーズ, インコーポレイテッド | グルタミナーゼ阻害剤との併用療法 |
DK3164394T3 (da) * | 2014-07-03 | 2020-05-04 | Univ Texas | Gls1-inhibitorer til behandling af sygdomme |
US10660861B2 (en) | 2014-07-09 | 2020-05-26 | The Johns Hopkins University | Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy |
WO2016014890A1 (en) * | 2014-07-24 | 2016-01-28 | Calithera Biosciences, Inc. | Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase |
JP2017523211A (ja) | 2014-08-04 | 2017-08-17 | ドレクセル ユニバーシティ | 新規化合物およびそれを用いてil−1r媒介性の疾患または障害を処置するかまたは寛解させる方法 |
BR112017002403A2 (pt) | 2014-08-07 | 2017-12-05 | Calithera Biosciences Inc | formas de cristais de inibidores de glutaminase |
WO2016160980A1 (en) * | 2015-03-30 | 2016-10-06 | Calithera Biosciences, Inc. | Methods of administering glutaminase inhibitors |
JP6944377B2 (ja) | 2015-04-06 | 2021-10-06 | キャリセラ バイオサイエンシーズ, インコーポレイテッド | グルタミナーゼの阻害剤を用いる肺がんの処置 |
ES2794868T3 (es) | 2015-06-30 | 2020-11-19 | Univ Texas | Inhibidores de GLS1 para el tratamiento de enfermedades |
JP6971239B2 (ja) | 2015-10-05 | 2021-11-24 | キャリセラ バイオサイエンシーズ, インコーポレイテッド | グルタミナーゼ阻害剤とイムノオンコロジー薬剤との併用療法 |
CN108602782B (zh) | 2015-12-22 | 2022-06-17 | 德克萨斯大学系统董事会 | N-甲基-1h-1,2,3-三唑-4-甲酰胺化合物的盐形式和多晶型物 |
KR20190040302A (ko) | 2016-08-25 | 2019-04-17 | 칼리테라 바이오사이언시즈, 인코포레이티드 | 글루타미나제 억제제와의 병용 요법 |
CN109982703A (zh) | 2016-08-25 | 2019-07-05 | 卡利泰拉生物科技公司 | 用谷氨酰胺酶抑制剂的组合疗法 |
CN107137401A (zh) * | 2017-03-28 | 2017-09-08 | 刘纪君 | 一种治疗产后抑郁症的药物组合物 |
RU2020112558A (ru) | 2017-10-18 | 2021-11-18 | Боард Оф Регентс, Зе Юниверсити Оф Тексас Систем | Терапия на основе ингибитора глутаминазы |
CN114805346A (zh) * | 2021-07-08 | 2022-07-29 | 成都硕德药业有限公司 | 杂环类衍生物、其制备方法及用途 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2037257A1 (en) * | 1970-07-28 | 1972-02-03 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn |
US4070400A (en) * | 1975-10-16 | 1978-01-24 | Merck & Co., Inc. | Diphenyl polyamides having a cyclohexylene moiety |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
CA2155759A1 (en) | 1993-03-29 | 1994-10-13 | Bernd Janssen | 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance |
US5895748A (en) | 1996-11-27 | 1999-04-20 | Johnson; Keith R. | Panel of antibodies for detecting cadherins and catenins in tissues and method of using the panel of antibodies |
DE69923681T2 (de) | 1998-06-18 | 2006-01-12 | Bristol-Myers Squibb Co. | Kohlenstoff substituierte aminothiazole als inhibitoren von cyclin-abhängigen kinasen |
WO2000052204A2 (en) | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
AU2001249064A1 (en) | 2000-02-22 | 2001-09-03 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
US6974667B2 (en) | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
US6451828B1 (en) * | 2000-08-10 | 2002-09-17 | Elan Pharmaceuticals, Inc. | Selective inhibition of glutaminase by bis-thiadiazoles |
DK1388734T3 (da) | 2002-08-01 | 2004-05-03 | Mtm Lab Ag | Metode til opløsningsbaseret diagnose |
WO2006040569A1 (en) | 2004-10-14 | 2006-04-20 | Astex Therapeutics Limited | Thiophene amide compounds for use in the treatment or prophylaxis of cancers |
US20080182865A1 (en) | 2005-03-11 | 2008-07-31 | Witta Samir E | Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
DE602006016085D1 (de) | 2005-03-16 | 2010-09-23 | Genentech Inc | Biologische marker prediktiv für das ansprechen von krebs auf inhibitoren der kinase des rezeptors für epidermalen wachstumsfaktor |
WO2008048967A1 (en) | 2006-10-16 | 2008-04-24 | University Of Rochester | Tripodal cyclohexane derivatives and their use as carbohydrate receptors |
CA2702462A1 (en) | 2007-11-19 | 2009-05-28 | Genentech, Inc. | Compositions and methods for inhibiting tumor progression |
JP2011516826A (ja) | 2008-03-07 | 2011-05-26 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 間葉系様腫瘍細胞またはこの形成を阻害する作用剤の同定のための方法 |
US20120190565A1 (en) | 2009-02-20 | 2012-07-26 | Pangea Biosciences, Inc. | Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm |
WO2010111504A2 (en) | 2009-03-25 | 2010-09-30 | Cornell University | Inhibition of glutaminase c |
US20120142028A1 (en) | 2009-04-17 | 2012-06-07 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
US20130109643A1 (en) | 2010-05-10 | 2013-05-02 | The Johns Hopkins University | Metabolic inhibitor against tumors having an idh mutation |
JP5944385B2 (ja) | 2010-06-23 | 2016-07-05 | ユニバーシティ オブ ルーイビル リサーチ ファウンデーション,インコーポレーテッド | 癌を検出するための方法 |
US10064885B2 (en) | 2010-07-09 | 2018-09-04 | Massachusetts Institute Of Technology | Metabolic gene, enzyme, and flux targets for cancer therapy |
UY33930A (es) | 2011-03-04 | 2012-10-31 | Novartis Ag | Inhibidores novedosos de quinasas |
CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
WO2013043125A1 (en) * | 2011-09-20 | 2013-03-28 | Temasek Life Sciences Laboratory Limited | Enterovirus 71 specific antibodies and uses thereof |
SG11201402305WA (en) * | 2011-11-21 | 2014-06-27 | Calithera Biosciences Inc | Heterocyclic inhibitors of glutaminase |
KR20140138956A (ko) | 2012-03-15 | 2014-12-04 | 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 | E-카드헤린의 세포외 도메인의 저해제를 포함하는 병용 치료법 |
EP2922832B1 (en) * | 2012-11-21 | 2019-10-09 | Agios Pharmaceuticals, Inc. | Glutaminase inhibitors and methods of use |
WO2014079011A1 (en) | 2012-11-22 | 2014-05-30 | Agios Pharmaceuticals, Inc. | Heterocyclic compounds for inhibiting glutaminase and their methods of use |
US9029531B2 (en) | 2012-11-22 | 2015-05-12 | Agios Pharmaceuticals, Inc. | Compounds and their methods of use |
WO2014138391A1 (en) | 2013-03-06 | 2014-09-12 | The Johns Hopkins University | Targeting glutamine metabolism in brain tumors |
JP6783663B2 (ja) | 2014-01-06 | 2020-11-11 | ライゼン・ファーマシューティカルズ・エスアー | 新規グルタミナーゼ阻害剤 |
EA201691896A1 (ru) | 2014-03-21 | 2017-01-30 | Аджиос Фармасьютикалз, Инк. | Соединения и способы их применения |
-
2013
- 2013-11-21 EP EP13808311.8A patent/EP2922832B1/en active Active
- 2013-11-21 ES ES13808311T patent/ES2761951T3/es active Active
- 2013-11-21 EA EA201590997A patent/EA029531B1/ru not_active IP Right Cessation
- 2013-11-21 MX MX2015006478A patent/MX369691B/es active IP Right Grant
- 2013-11-21 BR BR112015011756A patent/BR112015011756A2/pt not_active Application Discontinuation
- 2013-11-21 SG SG11201504022RA patent/SG11201504022RA/en unknown
- 2013-11-21 KR KR1020157016411A patent/KR20150085078A/ko not_active Application Discontinuation
- 2013-11-21 CA CA2892089A patent/CA2892089A1/en not_active Abandoned
- 2013-11-21 AU AU2013347933A patent/AU2013347933C1/en not_active Ceased
- 2013-11-21 US US14/085,947 patent/US9303002B2/en active Active
- 2013-11-21 JP JP2015544128A patent/JP6333280B2/ja not_active Expired - Fee Related
- 2013-11-21 WO PCT/US2013/071212 patent/WO2014081925A1/en active Application Filing
- 2013-11-21 US US14/646,239 patent/US10011574B2/en active Active
- 2013-11-21 CN CN201380070378.2A patent/CN105263915B/zh not_active Expired - Fee Related
-
2015
- 2015-05-21 IL IL238959A patent/IL238959A/en active IP Right Grant
-
2016
- 2016-02-18 HK HK16101849.3A patent/HK1213889A1/zh unknown
-
2018
- 2018-06-04 US US15/996,723 patent/US10414740B2/en not_active Expired - Fee Related
- 2018-06-28 AU AU2018204692A patent/AU2018204692A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2013347933B2 (en) | 2018-03-29 |
JP2016500107A (ja) | 2016-01-07 |
US20150299152A1 (en) | 2015-10-22 |
AU2013347933C1 (en) | 2018-10-04 |
JP6333280B2 (ja) | 2018-05-30 |
EA029531B1 (ru) | 2018-04-30 |
EP2922832A1 (en) | 2015-09-30 |
HK1213889A1 (zh) | 2016-07-15 |
SG11201504022RA (en) | 2015-06-29 |
IL238959A0 (en) | 2015-07-30 |
CN105263915A (zh) | 2016-01-20 |
US9303002B2 (en) | 2016-04-05 |
US20140142146A1 (en) | 2014-05-22 |
BR112015011756A2 (pt) | 2017-07-11 |
AU2013347933A1 (en) | 2015-06-11 |
MX369691B (es) | 2019-11-19 |
AU2018204692A1 (en) | 2018-07-19 |
EP2922832B1 (en) | 2019-10-09 |
US10414740B2 (en) | 2019-09-17 |
US20180370930A1 (en) | 2018-12-27 |
CN105263915B (zh) | 2019-04-12 |
CA2892089A1 (en) | 2014-05-30 |
KR20150085078A (ko) | 2015-07-22 |
US10011574B2 (en) | 2018-07-03 |
WO2014081925A1 (en) | 2014-05-30 |
ES2761951T3 (es) | 2020-05-21 |
EA201590997A1 (ru) | 2015-11-30 |
AU2013347933A2 (en) | 2015-07-09 |
IL238959A (en) | 2017-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX369691B (es) | Inhibidores de glutaminasa y métodos de empleo. | |
HK1252149A1 (zh) | 使用pd-l1亞型識別、評估、預防和治療癌症的組合物和方法 | |
ZA202208792B (en) | Methods of treating and preventing graft versus host disease | |
MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
MX2016007801A (es) | Pirimidopirimidinonas utiles como iniciadores de wee-1 cinasa. | |
HK1210957A1 (en) | Effluz inhibitor compositions and methods of treatment using the same | |
PH12016500330B1 (en) | Certain chemical entities, compositions, and methods | |
EA201590987A1 (ru) | Соединения и способы их применения | |
MX2020009256A (es) | Compuestos para el tratamiento de cancer. | |
IL273090B (en) | Methods and preparations for the treatment of cancer | |
EP3169363A4 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
HK1217289A1 (zh) | 使用細菌治療癌症的組合物和方法 | |
PH12016500270A1 (en) | Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases | |
MX2014012477A (es) | Inhibidores pirrolopirazona de tanquirasa. | |
MX2017006015A (es) | Composiciones para usar en el tratamiento de cancer renal. | |
MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
MX2014004991A (es) | Combinaciones terapeuticas y metodos para tratar el melanoma. | |
MX2015013021A (es) | 5-bromo-indirrubinas. | |
PH12016501838A1 (en) | Compounds and their methods of use | |
MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
MY182434A (en) | Certain chemical entities, compositions, and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |